IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors-Reference-Cited by-同舟云学术

IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors

Published:2012-05 Issue:5 Volume:132 Page:1392-1400
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Savinko Terhi,Matikainen Sampsa,Saarialho-Kere Ulpu,Lehto Maili,Wang Guoying,Lehtimäki Sari,Karisola Piia,Reunala Timo,Wolff Henrik,Lauerma Antti,Alenius Harri

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference44 articles.

1. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report;Akdis;J Allergy Clin Immunol,2006

2. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells;Allakhverdi;J Immunol,2007

3. Atopic dermatitis;Bieber;Ann Dermatol,2010

4. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation;Boguniewicz;Immunol Rev,2011

5. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB);Breuer;Allergy,2000

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational recognition of regulator genes and signature for ferroptosis with implications on immunological properties and clinical management of atopic dermatitis;Frontiers in Immunology;2024-09-06

2. Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials;Clinical and Translational Science;2024-07-30

3. Difamilast, a Topical Phosphodiesterase 4 Inhibitor, Produces Soluble ST2 via the AHR–NRF2 Axis in Human Keratinocytes;International Journal of Molecular Sciences;2024-07-19

4. Emerging Systemic Treatment Options in Atopic Dermatitis;Balkan Medical Journal;2024-07-05

5. Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege;British Journal of Dermatology;2024-06-11